Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension

Hypertension

Volumn 45, Issue 5, 2005, Pages 934-939

  Tian, Niu ^a   Thrasher, Kristina D ^a   Gundy, Paul D ^a   Hughson, Michael D ^a   Manning Jr , R Davis ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Hemodynamics; Hypertension; Renal disease

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; ATTENUATION; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMODYNAMIC MONITORING; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY MEDULLA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SODIUM INTAKE; STATISTICAL SIGNIFICANCE; VITAMIN INTAKE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; HEART RATE; HEMODYNAMIC PROCESSES; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY MEDULLA; MALE; PROTEINURIA; RATS; RATS, INBRED DAHL; RENAL CIRCULATION; SODIUM CHLORIDE; SUPEROXIDES; VITAMIN E;

EID: 18244400092     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000160404.08866.5a     Document Type: Article

References (24)

1. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension. 1994;23:195-199.
2. Chen PY, St. John PL, Kirk KA, Abrahamson DR, Sanders PW. Hypertensive nephrosclerosis in the Dahl/Rapp rat: Initial sites of injury and effect of dietary L-arginine supplementation. Lab Invest. 1993;68:174-184.
3. Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc. 2002;94(8 Suppl):7S-15S.
4. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press Res. 2001;24:116-123.
5. Luscher TF, Raij L, Vanhoutte PM. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in salt-induced hypertension of the rat. Hypertension. 1987;9:III193-III197.
6. Meng S, Cason GW, Gannon AW RL, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension. 2003;41:1346-1352.
7. Tian N, Gannon A, Khalil R, Manning RDJ. Mechanisms of salt-sensitive hypertension: Role of medullary inducible nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2002;284:R372-R379.
8. Meng S, Roberts LJ, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and Oxidative stress in Dahl salt-sensitive and - resistant rats. Am J Physiol Regul Integr Comp Physiol. 2002;283:R732-R738.
9. Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol. 2003;42:82-88.
10. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension. 2003;41:592-597.
11. Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol. 2002;80:1199-1202.
12. Nishikawa Y, Tatsumi K, Matsuura T, Yamamoto A, Nadamoto T, Urabe K. Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2003;49:301-309.
13. Reckelhoff JF, Kanji V, Racusen LC, Schmidt AM, Yan SD, Marrow J, Roberts LJ, Salahudeen AK. Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. Am J Physiol. 1998;274(3 Pt 2):R767-R774.
14. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke- prone SHR. Hypertension. 2001;38(3 Pt 2):606-611.
15. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, Omata M. Vitamin E ameliorates the renal injury of Dahl Salt-sensitive Rats. Am J Hypertens. 1997;10:116s-119s.
16. Attia DM, Verhagen AM, Stroes ES, van Faassen EE, Grone HJ, De Kimpe SJ, Koomans HA, Braam B, Joles JA. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol. 2001;12:2585-2593.
17. Roberts LJ, II, Oates JA, Fazio S, Gross MD, Linton MF, Morrow JD. Alpha tocopherol supplementation reduces plasma F2-isoprostane concentrations in hypercholesterolemic humans only at doses of 800 IU or higher. Free Rad Biol Med. 2002;33(Suppl 2):S412.
18. Laakso J, Mervaala E, Himberg JJ, Teravainen TL, Karppanen H, Vapaatalo H, Lapatto R. Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension. 1998;32:902-906.
19. Swei A, Lacy F, Delano FA, Parks DA, Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation. 1999;6:179-187.
20. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr., Vita JA. Treatment of hypertension with ascorbic acid. Lancet. 1999;354:2048-2049.
21. Hoogwerf BJ, Young JB. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med. 2000;67:287-293.
22. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;23:347:781-786.
23. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;7:356:1213-1218.
24. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha- tocopherol (vitamin E). Circ Res. 2000;87:349-354.